Home
Resources
Product Analysis
Acknowledgements
About
Home
References
Funding types
Funding types
Shareholder Investment
Products 71 to 80 of 129
Modify Display Properties
Biotech components
Business models
Country of production
Country of distribution
Intended consumer
Date added
Date last modified
Known funding amount
Funding types
Industry
Market status
Organization
Organization type(s)
Product categories
Production process
Source
Trading symbol
Value chain stage
Sort: Title (A-Z)
Date added (oldest-newest)
Date added (newest-oldest)
Date modified (oldest-newest)
Date modified (newest-oldest)
Title (A-Z)
Title (Z-A)
Organization (A-Z)
Organization (Z-A)
Metabolix DP 9002 for Denitrification in Aquariums
by
Yield10 Bioscience
Biotech components:
Bacteria
Business models:
B2C
Country of production:
USA
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
41,800,000 USD
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
Market status:
No longer on the market
Organization type(s):
Public Company
Product categories:
Chemical
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
YTEN
(NASDAQ)
Value chain stage:
Finished Product
Methane bioconversion: 1,4 BDO
by
Intrexon
Biotech components:
Bacteria
+
Gene Editing
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/13 11:47 (5 years ago)
Date last modified:
2019/09/13 11:47 (5 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Energy
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Fuel and Energy
Production process:
N/A
Source:
N/A
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Input
Methane bioconversion: 2,3 BDO
by
Intrexon
Biotech components:
Bacteria
+
Gene Editing
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/13 11:47 (5 years ago)
Date last modified:
2019/09/13 11:47 (5 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Energy
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Chemical
+
Fuel and Energy
Production process:
N/A
Source:
Web search
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Input
Methane bioconversion: Farnesene
by
Intrexon
Biotech components:
Bacteria
+
Gene Editing
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/13 11:47 (5 years ago)
Date last modified:
2019/09/13 11:47 (5 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Energy
+
Industrial
Market status:
Early Stage Concept
Organization type(s):
Public Company
Product categories:
Fuel and Energy
+
Chemical
Production process:
N/A
Source:
N/A
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Input
Methane Bioconversion: Isobutanol
by
Intrexon
Biotech components:
Bacteria
+
Gene Editing
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/13 11:47 (5 years ago)
Date last modified:
2019/09/16 16:29 (5 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Energy
+
Industrial
Market status:
Early Stage Concept
Organization type(s):
Public Company
Product categories:
Fuel and Energy
+
Chemical
Production process:
N/A
Source:
Web search
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Finished Product
Methane bioconversion: Isobutyraldehyde
by
Intrexon
Biotech components:
Bacteria
+
Gene Editing
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/13 11:47 (5 years ago)
Date last modified:
2019/09/13 11:47 (5 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Energy
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Fuel and Energy
Production process:
N/A
Source:
Web search
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Input
Methane bioconversion: isoprene
by
Intrexon
Biotech components:
Bacteria
+
Gene Editing
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/13 11:47 (5 years ago)
Date last modified:
2019/09/13 11:47 (5 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
Early Stage Concept
Organization type(s):
Public Company
Product categories:
Chemical
+
Other (Industrial)
Production process:
N/A
Source:
N/A
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Input
Microbe-Derived Dielectric Fluids
by
Tarravia
+
Solazyme
+
Dow Chemical Company
Biotech components:
Plant
Business models:
B2B
Country of production:
USA
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2019/05/15 16:13 (6 years ago)
Known funding amount:
174,900,000 USD
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Fuel and Energy
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
SZYM
(NASDAQ)
Value chain stage:
Input
Mirel P1003, F1005 for Injection Molding
by
Yield10 Bioscience
Biotech components:
Plant
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
41,800,000 USD
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
No longer on the market
Organization type(s):
Public Company
Product categories:
Fiber
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
YTEN
(NASDAQ)
Value chain stage:
Input
Mirel P1004, F1006 for Injection Molding
by
Yield10 Bioscience
Biotech components:
Plant
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
41,800,000 USD
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
No longer on the market
Organization type(s):
Public Company
Product categories:
Fiber
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
YTEN
(NASDAQ)
Value chain stage:
Input
1
…
3
4
5
6
7
8
9
10
11
12
…
13
Login
or
register
to add and edit products
Future
Bioengineered
Products
Home
Resources
Product Analysis
Acknowledgements
About
